Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

NCT05746182 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05746182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05746182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
April 7, 2023
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neuroendocrine neoplasm